The behavioral pharmacology of hallucinogens
Authors:
- William E. FantegrossiWilliam E. Fantegrossi
- Kevin S. MurnaneKMKevin S. Murnane
- 1 January 2008
- journal article
- review article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 75 (1) , 17-33
Abstract
No abstract availableKeywords
This publication has 168 references indexed in Scilit:
- Prefrontal cortical network activity: Opposite effects of psychedelic hallucinogens and D1/D5 dopamine receptor activationNeuroscience, 2007
- Endogenous psychoactive tryptamines reconsidered: an anxiolytic role for dimethyltryptamineMedical Hypotheses, 2005
- Brain monoamine receptors in a chronic unpredictable stress model in ratsJournal of Neural Transmission, 2001
- Agonist high and low affinity state ratios predict drug intrinsic activity and a revised Ternary complex mechanism at serotonin 5-HT2A and 5-HT2C receptorsSynapse, 1999
- Serotonin and HallucinogensNeuropsychopharmacology, 1999
- Serotonin and HallucinogensNeuropsychopharmacology, 1999
- Autoradiographic Characterization, Anatomical Distribution, and Developmental Pattern of a New 5-HT Site in Human BrainAnnals of the New York Academy of Sciences, 1998
- Electrophysiological responses of serotoninergic dorsal raphe neurons to 5‐HT1A and 5‐HT1B agonistsSynapse, 1987
- Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agentsLife Sciences, 1984
- Response of central monoaminergic neurons to lisuride: Comparison with LSDLife Sciences, 1979